Robert Mangas

🏛️ Revolving Door

Former Government Position:

Chief of Staff (95-98) & Counsel (87-94), Senator Wendell Ford

Share:𝕏LinkedInFacebook
🤖

AI Overview

Robert Mangas has appeared in 695 federal lobbying filings at Greenberg Traurig, LLP, representing 31 clients. As a former government official, they bring insider expertise to their lobbying work — part of Washington's "revolving door." Active across 36 policy areas.

695
Total Filings
1
Firms
31
Clients
36
Issue Areas

Issue Areas

CPTARTGOVENGTARTRDTAXBUDENVCHMHCRLBRAGREDUMEDSCIECNRESURBRETTRAIMMFINSMBCPIAUTCAWTECFORBNKMANDEFAVIFUEFOOMMM

Filing History

YearFilingsClients
2018989
2019705
2020747
20219211
202210311
202311411
2024608
20258411

Firms

Greenberg Traurig, LLP695 filings

Top Clients

Covestro LLC216 filings
Life Molecular Imaging (F/K/A Piramal Imaging Limited)72 filings
Neste US, INC.54 filings
Dell Technologies, INC.47 filings
Peabody Energy45 filings
Bayer Corporation37 filings
International Education Corporation26 filings
Amerihealth Caritas22 filings
Intuit INC.21 filings
Mckinsey & Company21 filings
Canon Nanotechnologies, INC.21 filings
Alibaba Group Holding Limited20 filings
Alen Corp12 filings
Guidepoint Systems10 filings
Alberta Development Partners, LLC9 filings
Stellar Energy7 filings
Ngl Energy Partners6 filings
Ono Pharmaceutical Co., LTD (Formerly Ono Pharma USA)6 filings
C&s Wholesale Grocers INC.6 filings
Boralex US Development, LLC6 filings

Related Analysis

🏛️ Revolving Door Premium
Do ex-government lobbyists earn more?
🕸️ Network Analysis
Explore connections between firms and lobbyists
🎯 Market Concentration
How concentrated is the lobbying market?

Related Investigations

The Revolving Door Exposed
How former government officials become the most powerful lobbyists.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
The 22,000% ROI
When lobbying spending yields outsized returns.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Follow the Money
Tracking lobbying dollars through the financial system.

Explore More

← All Lobbyists🏛️ Revolving Door🕸️ Network Analysis🏛️ Agency Pressure 🔍 Investigations

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.